GeoVax Labs Boosts Investor Appeal With 1‑for‑24 Reverse Stock SplitGeoVax Labs’ 1‑for‑24 reverse stock split boosts investor appeal while the firm tackles funding gaps to advance its HIV‑1 vaccine pipeline.GEOVAX LABS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 14/11/2026, 08:06 2 minutes to read